ArticleTherapeutic advances in medical oncology2022

Clearance of ctDNA in triple-negative and HER2-positive breast cancer patients during neoadjuvant treatment is correlated with pathologic complete response.

Nikaoly Ciriaco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.